Nanomol Technologies has been present in Catalan media (Televisió de Catalunya TV3 and La Vanguardia) with the announcement that together with The Center of Genetic Engineering and Biotecnology (CIGB-Biocubafarma) and Heber Biotec it has started to clinically validate a new drug that aims at improving the healing of diabetic foot ulcers and preventing amputation.
More information at:
http://www.ccma.cat/tv3/alacarta/valor-afegit/fer-negocis-despres-de-fidel/video/5636552/
http://www.ccma.cat/tv3/alacarta/telenoticies-migdia/telenoticies-migdia-07122016/video/5636311/
http://icmab.es/images/attachments/2016/Reportatge_NANOMOL_TECH_La_Vanguardia_18_12_2016_CAT.pdf